All oligos, sgRNA, and primers used in this study are listed in Supplementary Table 1 . The pLV3-CMV-KHDRBS1-EGFP-Puro plasmid and its corresponding control, pLV3-CMV-EGFP-Puro, were procured from Miaoling Biology (Wuhan, China). KHDRBS1 sgRNA was custom-designed, synthesized, and then ligated into the lentiCRISPR-EGFP vector. This construct was employed to generate the lentiCRISPR-EGFP sgRNA construct, which was subsequently verified by DNA sequencing. Transfections were carried out using.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.